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Abstract
Background: Left ventricular diastolic dyssynchrony is common in patients with heart failure with 
reduced ejection fraction (HFREF). Little is known however, about its pathophysiology and clinical 
effects. Herein is hypothesized that presence of diastolic dyssynchrony at rest or at exercise may impor-
tantly contribute to HF symptoms. The aim was to investigate the influence of diastolic dyssynchrony 
and its exercise-induced changes on exercise capacity in HFREF patients.
Methods: Patients with stable, chronic HF, left ventricular ejection fraction < 35%, sinus rhythm 
and QRS ≥ 120 ms were eligible for the study. Rest and cyclo-ergometer exercise echocardiography were 
performed. Diastolic dyssynchrony was defined as opposing-wall-diastolic-delay ≥ 55 ms measured in 
tissue-Doppler imaging. Exercise capacity was assessed by peak oxygen consumption (VO2peak). Asso-
ciation between diastolic dyssynchrony and VO2peak was assessed in univariate regression analysis and 
further adjusted for possible confounders.
Results: Fourty eight patients were included (aged 63.7 ± 12.2). Twenty-seven (56.25%) had diastolic 
dyssynchrony at rest and 13 (27%) at exercise. Twenty-two (46%) experienced a change in diastolic 
dyssynchrony status during exercise. In univariate models diastolic dyssynchrony at rest or at exercise 
were associated with lower VO2peak (beta coefficient = –3.8, p = 0.004; beta coefficient = –3.6, p = 0.02, 
respectively). However, the ability to restore diastolic synchronicity during exercise was associated with 
higher VO2peak (beta coefficient = 3.4, p = 0.04) and remained an important predictor of exercise capac-
ity after adjustment for age and HF etiology.
Conclusions: The ability to restore diastolic synchronicity at exercise predicts exercise capacity in 
patients with HFREF. (Cardiol J XXXX; XX, X: xx–xx)
Key words: stress echocardiography, cardiopulmonary exercise test, ischemic  
cardiomyopathy, QRS prolongation, cardiac resynchronization therapy
Introduction
Mechanical dyssynchrony results from the 
incoordinate wall motion of different ventricular 
segments. It may occur not only in systole, but also 
in diastole. While systolic dyssynchrony has been 
shown to be an important contributor to the left 
ventricular (LV) dysfunction in a wide spectrum of 
heart failure (HF) patients, little is known on the 
pathophysiology and clinical effects of diastolic 
dyssynchrony, although diastolic dyssynchrony 
has been frequently observed both in HF patients 
with reduced (HFREF) and preserved (HFPEF) 
ejection fraction [1–5]. 
Most evidence regarding diastolic dyssyn-
chrony come from studies on patients with HFPEF. 
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Diastolic dyssynchrony in this population was 
found to aggravate LV diastolic dysfunction [5]. 
It was associated with the LV hypertrophy and 
increased LV mass [5]. Interestingly, initiation of 
medical therapy has shown to favor improvement 
of diastolic dyssynchorny. Patients with HFPEF, in 
whom treatment with diuretics, when beta-block-
ers and angiotensin-converting enzyme inhibitors 
or angiotensin receptor antagonists were initiated, 
experienced a significant decrease in diastolic dys-
synchrony [5].
In contrast, an understanding of the patho-
physiology and clinical effects of diastolic dys-
synchrony in HFREF patients remains deficient. 
It was found, that diastolic dyssynchrony occurs 
at least as frequent as systolic, although the coex-
istence of systolic and diastolic dyssynchrony is 
low, suggesting that the mechanisms of these two 
phenomena may exhibit some differences [3]. The 
presence of diastolic dyssynchrony was observed 
more often in patients with wider QRS duration 
and was linked to worse diastolic LV function [1]. 
It was also associated with an adverse prognosis in 
children with dilated cardiomyopathy [6]. Eventu-
ally, cardiac resynchronization therapy (CRT) was 
found to improve diastolic dyssynchrony, however 
the role of diastolic dyssynchrony in CRT patient 
selection is less clear [3]. 
Data on the influence of diastolic dyssynchrony 
on exercise capacity in patients with HFREF is 
lacking. It was also unknown as to whether diastolic 
dyssynchrony is prone to change during exercise 
as had previously been reported with regard to 
systolic dyssynchrony [7].
Limitation of exercise capacity is the main 
symptom of HF, hence the aim in the present 
study to investigate the influence of diastolic dys-
synchrony on exercise capacity in HFREF patients 
with prolonged QRS duration, and to analyse the 




Consecutive HFREF patients considered 
for CRT device implantation at a single tertiary 
cardiology department between 2013 and 2014 
were included in this study. Patients were en-
rolled in the study if they classified in the New 
York Heart Association (NYHA) functional class 
II–IV despite optimal medical therapy and had 
no further coronary revascularization options, 
presented with LV ejection fraction (LVEF) ≤ 
35%, were in sinus rhythm and had QRS duration 
≥ 120 ms on a 12-lead electrocardiogram. Patents 
with any HF exacerbations within past 3 months 
were not eligible for the study. Exclusion criteria 
also included a history of any cardiac implantable 
electronic devices, persistent atrial fibrillation, 
significant respiratory, neurological or orthopaedic 
disorder limiting exercise capabilities. Ischemic 
etiology (ischemic cardiomyopathy [ICM]) of the 
HF was defined based on a history of myocardial 
infarction, coronary revascularization or presence 
of angiographically significant stenotic coronary 
lesions. Otherwise the patients were diagnosed 
with non-ischemic cardiomyopathy (DCM). 
All patients provided written informed con-
sent to participate in this study. The study was 
performed in accordance with the Declaration of 
Helsinki and was approved by the Institutional 
Ethical Committee at the Jagiellonian University 
in Krakow, Poland (KBET/110/B/2013). 
All measurements and patient medical re-
cords were prospectively acquired by the authors 
themselves.
Echocardiography
A Vivid 7 device (GE Medical System, Horten, 
Norway) was used, equipped with phased-array 
3.5-MHz transducer and tissue Doppler imaging 
(TDI) software to perform echocardiographic ex-
aminations in all patients. The recordings were ana-
lysed offline on EchoPac software (GE Vingmed, 
Horten, Norway) after digital storage. Conven-
tional 2-dimensional and Doppler parameters were 
calculated in apical 4-, 3- and 2-chamber views. 
TDI data were recorded with the highest attain-
able frame rate. Six basal LV time-velocity curves 
(TVI) were reproduced offline from stored TDI 
color images to analyse LV systolic and diastolic 
dyssynchrony. All measurements were performed 
by experienced echocardiographers by averaging 
at least 3 consecutive heart beats. 
The LV systolic function was determined by 
LVEF, calculated using the Simpson biplane method 
[8]. The LV diastolic function was quantified by the 
ratio of the early diastolic mitral velocity (E) ac-
quired with the pulsed-wave Doppler, to the mean 
septal and lateral mitral annulus early diastolic 
velocity (e’) obtained by the TDI-derived pulsed-
wave (E/e’) [9].
Exercise stress echocardiography
Symptom-limited exercise echocardiography 
was performed on cycle ergometer (Ergoline 9000 
Ergoline GmbH, Bitz, Germany) in a semi-recum-
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bent position with the initial workload of 20 Watts 
increasing every 2 min by 20 Watts. Echocardio-
graphic data were recorded throughout the exercise 
and stored for subsequent off-line analysis. Peak 
exercise measurements were derived from at least 
3 heart beats in the last 2-min cycle and are ex-
pressed as means. Pharmacotherapy was continued 
without change at the time of stress tests.
Diastolic and systolic LV dyssynchrony
Calculations of the LV diastolic and systolic 
dyssynchrony were performed at rest and at peak 
exercise for each patient. 6 LV basal TVIs were 
applied to measure time-to-peak early diastolic 
myocardial velocity intervals (Te) from the onset of 
QRS complex to the peak early diastolic myocardial 
velocity to analyse diastolic dyssynchrony (Fig. 1), 
and time-to-peak systolic velocity intervals (Ts) 
from the onset of QRS complex to the peak myo-
cardial systolic velocity in order to analyse systolic 
dyssynchrony. The differences between Te and 
Ts of opposing wall segments were calculated to 
determine opposing wall diastolic and systolic de-
lays. In order to eliminate the effect of heart rate 
on measurements of dyssynchrony parameters and 
to allow for comparison of rest and exercise dys-
synchrony status, Te and Ts delays were corrected 
for RR intervals using the Bazzet formula [10]. At 
least one corrected opposing wall diastolic delay 
greater or equal to 55 ms was indicative for rest 
and exercise diastolic dyssynchrony, as previously 
described [3]. Similarly, at least one corrected 
opposing wall systolic delay greater or equal to 
65 ms was indicative for rest an exercise systolic 
dyssynchrony [11].
Exercise-induced diastolic resynchronization 
was defined as change from the presence of dias-
tolic dyssynchrony at rest to absence of diastolic 
dyssynchrony at exercise. In contrast, occurrence 
of diastolic dyssynchrony during exercise if not 
Figure 1. An example of diastolic dyssynchrony evaluation on the myocardial velocity imaging curves. The yellow 
curve represents basal segment of the interventricular septum (IVS) and the green, a basal segment of the lateral wall 
(LAT). Line 1 and 2 measure the time-to-peak early diastolic myocardial velocity interval (Te) of the IVS (line 1) and the 
LAT (line 2) from the onset of the QRS. Line 3 shows the difference between the IVS Te and the LAT Te representing 
an opposing wall Te delay.
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present at rest was indicative of exercise-induced 
diastolic dyssynchronization.
Cardiopulmonary exercise test 
The treadmill cardiopulmonary exercise test 
(CPET) was employed to determine exercise 
capacity. The tests were conducted on a separate 
day than stress echocardiography. The CPET 
was performed using Reynolds Medical TMX425 
TRACKMASTER treadmill unit with continu-
ous breath-by-breath measurement of oxygen 
consumption (VO2), carbon dioxide production 
(VCO2), and minute ventilation (VE) on Reynolds 
Medical ZAN-600 respiratory gas analyzer. Modi-
fied Naughton protocol was applied in all patients 
[12]. VO2peak was defined as the highest value of 
oxygen uptake attained in the final 30 s of exercise 
and was presented as a weighted variable (mL/kg/
min) and as a percentage of age and sex predicted 
maximal exercise oxygen consumption. Anaerobic 
threshold was defined as the submaximal VO2 level 
when there is a dislinear rise in VE and VCO2 and 
expressed as mL/kg/min. Respiratory exchange 
ratio was calculated as the VCO2/VO2.
Statistical analysis
Categorical variables were described as counts 
and percentages and continuous variables as means 
± standard deviations or median and interquartile 
range. the unpaired Student’s t-test was used for 
normally distributed variables, the Mann-Whitney 
U-test for non-normally distributed continuous 
data, and the c2 test for categorical data to compare 
patients with and without diastolic dyssynchrony. 
With the use of univariate regression analysis the 
association between VO2peak (dependent variable) 
were examined and its potential modifiers (inde-
pendent variables) including  age, sex (0 — male, 
1 — female), HF etiology (0 — DCM, 1 — ICM), 
serum hemoglobin level, PR interval, QRS duration 
and morphology (0 — non-left bundle branch block 
[LBBB], 1 — LBBB), markers of the LV systolic 
(LVEF) and diastolic function (E/e’ ratio), the pres-
ence of rest and exercise diastolic and systolic dys-
synchrony (0 — not present, 1 — present) and the 
presence of exercise-induced diastolic resynchro-
nization and exercise-induced dyssynchronization. 
Significant associations were further adjusted the 
for age and etiology. The significance level was set 
at p < 0.05. Statistical analyses were performed 
with Statistica PL software (StatSoft, Inc. 2017, 
STATISTICA, data analysis software system, ver-
sion 13.1; www.statsoft.com) and MedCalc version 
11.6.1.0 (MedCalc Software, Mariakerke, Belgium).
Results
Characteristics of the patients studied
Between 2013 and 2014 we recruited 54 patients. 
Further analyses were based on 48 patients aged 63.7 
± 12.2 (39; 81.3% males) with a sufficient quality of 
echocardiographic data. The majority of patients (30; 
62.5%) were in NYHA class III. Medical treatment 
of the patients studied complied with contemporary 
guidelines [13]. A summary of clinical characteristics 
of the study group is presented in Table 1.
Rest and stress echocardiography
The mean LVEF was reduced (23.6 ± 6%) and 
the LV diastolic function was decreased with the 
mean E/e’ ratio of 17.1 ± 8. 
Exercise cardiac echo studies were performed 
without significant adverse events. Stress exami-
nations were terminated at the mean workload of 
76.2 ± 30.5 Watts and the mean heart rate of 115.4 ± 
±  22.1 bpm. Echocardiographic parameters are 
presented in Table 1.
Diastolic LV dyssynchrony  
at rest and at exercise
Diastolic dyssynchrony at rest was identified 
in 27 (56.3%) patients, mainly in males (25; 93%) 
and patients with ICM were (17; 63%). The group 
with diastolic dyssynchrony compared to the 
group without had similar LV systolic and diastolic 
function and a similar proportion of patients with 
systolic dyssynchrony. A detailed comparison of 
clinical parameters between patients with and 
without diastolic dyssynchrony is summarized 
in Table 1. 
Exercise echocardiography revealed the pres-
ence of exercise diastolic dyssynchrony in 13 (27%) 
patients. Twenty-two (46%) patients experienced 
a change in the diastolic dyssynchrony status 
under exercise. Exercise-induced diastolic re- 
synchronization was present in 18 (66.6%) pa-
tients and provoked diastolic dyssynchrony in 
4 (19%) patients (Fig. 2). A detailed comparison 
of clinical parameters between patients who 
remained synchronized during exercise or be-
came dyssynchronized and between patients who 
remained dyssynchronized or resynchronized 
during exercise is presented in Supplementary 
Table 1.
Diastolic dyssynchrony  
and exercise capacity 
The CPET was performed in every patient 
but the full protocol was obtained in 41 (85%). 
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Table 1. Characteristics of the patients studied.









Age [years] 63.7 ± 12.2 63.5 ± 9.6 63.8 ± 14 0.93
Women/men 9 (18.7%)/39 (81.3%) 7 (33%)/14 (67%) 2 (7%)/25 (93%) 0.02
Body mass index [kg/m2] 26.5 ± 3.8 25.9 ± 4.2 26.9 ± 3.5 0.37
Ischemic/non-ischemic 23 (47.9%)/25 (52.1%) 6 (29%)/15 (71%) 17 (63%)/10 (37%) 0.02
NYHA: 0.58
II 12 (25%) 6 (29%) 6 (22%)
III 30 (62.5%) 13 (62%) 17 (63%)
IV 6 (12.5%) 2 (9%) 4 (15%)
NT-proBNP [pg/mL] 1667 [503–3309] 1206 [532–2665] 1744 [479–4888] 0.47
Hemoglobin [g/dL] 14.4 ± 1.2 14.4 ± 1 14.3 ± 1.3 0.7
Heart rate [bpm] 70.6 ± 8.9 71.2 ± 8.8 70,1 ± 9.1 0.69
QRS duration [ms] 150 [120–160] 160 [120–160] 140 [120–160] 0.51
PR [ms] 200 [160–220] 180 [160–200] 200 [160–220] 0.08
LBBB/non-LBBB 28 (58.3%)/20 (41.7%) 11 (52%)/10 (48%) 17 (63%)/10 (37%) 0.46
Beta-blocker 47 (97.9%) 21 (100%) 26 (96%) 0.37
ACEI or ARB 47 (97.9%) 20 (96%) 27 (100%) 0.25
Aldosterone receptor antagonist 43 (89.6%) 18 (86%) 25 (93%) 0.44
Loop diuretics 44 (91.6%) 18 (86%) 26 (96%) 0.18
LVEF [%] 23.6 ± 6.0 23.5 ± 6.6 23.7 ± 5.7 0.91
E/e’ ratio 17.1 ± 8.1 15.3 ± 6.2 18.5 ± 9.2 0.17
Max Te delay [ms] 60 [40–80] 40 [30–45] 80 [60–98] < 0.001
Systolic dyssynchrony 32 (66.6%) 15 (71%) 17 (63%) 0.54
NYHA — New York Heart Association; NT-proBNP — N-terminal prohormone of B-type natriuretic peptide; LBBB — left bundle branch block; 
ACEI — angiotensin converting enzyme inhibitor; ARB — angiotensin receptor blocker; LVEF — left ventricular ejection fraction; E/e’ — ratio 
of early diastolic mitral velocity to early diastolic velocity of the mitral annulus; max Te delay — maximal opposing wall diastolic delay
Number of patients with diastolic dyssynchrony at rest, 
who resynchronized at exercise
Number of patients without diastolic dyssynchrony at rest, 
who remained synchronized at exercise
Patients with diastolic dyssynchrony at exercise
N = 9
N = 18 N = 17
N = 4
Figure 2. Exercise related changes of diastolic dyssyn-
chrony. The first column shows proportion of patients with 
diastolic dyssynchrony at rest, who restored synchronicity 
at exercise (gray square) and those, who remained dys-
synchronized (black square); The second column shows 
proportion of patients without diastolic dyssynchrony at 
rest, who remained synchronized at exercise (blue square) 
and those who dyssynchronized (black square).
Seven patients refused to complete the test due 
to anxiety for exercising on the treadmill or light-
headedness. Detailed CPET results are shown in 
Table 2. Lower VO2peak was associated with more 
advanced age, ischemic etiology of HF, longer PR 
interval, higher E/e’ ratio, the presence of rest and 
exercise diastolic dyssynchrony and lack of dias-
tolic resynchronization at exercise (Table 3). After 
adjustment for age and etiology, exercise induced 
diastolic resynchronization (beta coefficient = 3.4; 
95% confidence interval [CI] 0.17 to 6.6; p = 0.04), 
E/e’ (beta coefficient = –2.0; 95% CI –0.06 to 
–0.34; p = 0.006) and PR interval (beta coeffi-
cient = –0.05; 95% CI –0.02 to –0.08, p = 0.004) 
were significantly associated with VO2peak (Table 3). 
A comparison of mean VO2peak between patients 
without rest diastolic dyssynchrony, who remained 
synchronized at exercise and those who dys-
synchronized at exercise, and between patients 
with rest diastolic dyssynchrony, who remained 
dyssnchronized at exercise and those who resyn-
chronized at exercise is shown in Figure 3.
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Discussion
There are two major findings in this study. 
First, diastolic dyssynchrony may change during 
exercise. Some patients with diastolic dyssyn-
chrony at rest experienced diastolic resynchroniza-
tion during exercise, while some of those without 
diastolic dyssynchrony at rest, became dyssyn-
chroneous at exercise. Although such dynamic 
features have previously been attributed to systolic 
dyssynchrony in patients with HFREF [7, 14].  Ac-
cording to available research this is the first report 
on the dynamic nature of diastolic dyssynchrony. 
 The presence of diastolic dyssynchrony was 
also found, both at rest and exercise, was associ-
ated with decreased exercise capacity in HFREF 
patients, but diastolic resynchronisation during 
exercise improved this. 
Similarly, a negative effect of diastolic dys-
synchrony on exercise capacity was reported in 
hypertensive patients with LV hypertrophy. In this 
group of patients diastolic dyssynchrony was also 
associated with decreased exercise capacity [15]. 
Impaired LV synchronicity may occur not only 
during ventricular contraction, but also during ven-
tricular relaxation. In fact, diastolic dyssynchrony 
was found to be at least as frequent as systolic. The 
prevalence of LV diastolic dyssynchrony in patients 
with HFREF and prolonged QRS duration ranged 
from 52% to 73% as compared to systolic (46–73%) 
Table 3. Associations between clinical, electro- and echocardiographic variables and VO2peak.
Variable Univariate analysis Associations after adjustment 
for age and etiology 
Beta coefficient 
(95% CI)
P Beta coefficient 
(95% CI)
P
Age [years] –0.17 (–0.3 to 0.05) 0.006
Etiology [0 — non-ischemic; 1 — ischemic] –4.7 (–6.8 to –2.1) 0.0005
PR interval [ms] –0.06 (–0.1 to –0.03) 0.0013 –0.05 (–0.08 to –0.02) 0.004
QRS duration [ms] 0.05 (–0.01 to 0.12) 0.1
LBBB [0 — absent; 1 — present] 0.4 (–2.4 to 3.2) 0.78
LVEF [%] 0.09 (–0.13 to 0.32) 0.38
E/e’ –0.27 (–0.4 to –0.12) 0.0006 –2.0 (–0.34 to –0.06) 0.006
Rest diastolic dyssynchrony –3.8 (–6.35 to –1.3) 0.004
Exercise diastolic dyssynchrony –3.6 (–6.6 to –0.6) 0.02
Exercise-induced diastolic resynchronization 3.4 (0.2 to 6.6) 0.04 3.4 (0.17 to 6.6) 0.04
Rest systolic dyssynchrony 1.5 (–1.3 to 4.4) 0.28
VO2peak — peak oxygen consumption; LBBB — left bundle branch block; LVEF — left ventricular ejection fraction; E/e’ — ratio of early diastolic 
mitral velocity to early diastolic velocity of the mitral annulus
Table 2. Cardiopulmonary exercise tests parameters.









Time of exercise [s] 555 ± 234 661 ± 247 510 ± 218 0.14
Exercise load [METs] 5.4 [4.4–6.3] 5.4 [4.4–7.4] 4.7 [3.4–5.4] 0.16
VO2peak [mL/kg/min] 15.5 ± 4.3 17.8 ± 4 13.9 ± 4 0.004
Percentage of predicted VO2max [%] 57.9 ± 18.6 65.4 ± 23.5 52.4 ± 11.6 0.04
Anaerobic threshold [mL/kg/min] 11 [7.1–14.5] 11.7 [8.9–16.7] 7.8 [6.9–12.1] 0.14
VE/VCO2 31 [27.3–37] 28 [25.1–30.4] 33.3 [30.1–39.5] < 0.001
Respiratory exchange ratio 1.03 [0.96–1.12] 1.03 [0.96–1.09] 1.03 [0.95–1.14] 0.62
VO2peak — peak oxygen uptake; VO2max — maximal exercise oxygen consumption; VE/VCO2 — minute ventilation to carbon dioxide production ratio
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[1–3]. In the present study diastolic dyssynchrony 
was present in more than a half of the patients. 
A concurrent presence of systolic and diastolic 
dyssynchrony in the current study was seen in 
35% of patients. A similar coincidence was shown 
in previous observations [1, 2]. This would suggest 
that systolic and diastolic dyssycnhrony may have 
some different pathophysiologies.
Intraventricular diastolic dyssynchrony reflects 
inhomogeneous timing of relaxation in different 
myocardial segments [16]. In healthy hearts, all LV 
segments relax in an organized fashion producing 
suction forces at the most efficient energy consump-
tion level. This is achieved by synchronous interplay 
between uninterrupted stimulation and undisturbed 
regional relaxability of cardiac myocytes. In the pres-
ence of diastolic dyssynchrony, relaxation of the LV 
becomes inefficient. Early diastolic discoordinate 
motion of the LV walls may cause impairment of the 
LV filling dynamics decreasing left atrial function, 
aggravating mitral regurgitation, adversely affecting 
right-to-left ventricular interaction and concomi-
tantly hinder ejection properties [17, 18]. As cardiac 
output is dependent not only on systolic emptying 
but also on diastolic filling, diastolic dyssynchrony 
may cause additive hemodynamic compromise in a 
failing heart. Decreased global performance of the 
heart at an increased workload promotes conse-
quently, in chronic unfavourable cardiac remodelling 
leading to a worsening of symptoms [19].
The causes of diastolic dyssynchrony has been 
less well understood. As systole and diastole are 
closely linked, it would be most expected that 
systolic asynchrony determined the presence of 
diastolic dyssynchrony. However, as discussed 
earlier, less than one-half of the HFREF patients 
have a coexistent systolic and diastolic dyssyn-
chrony. This lack of concurrence may in part be 
attributed to the regional heterogeneity of the 
load-induced relaxation delay. It has been previ-
ously demonstrated in experimental studies, that 
global LV afterload translates to regional loading 
conditions in an ununiformed fashion [20, 21]. It 
was shown, that regional myocardial load correlates 
with the timing of local relaxation [22]. Differences 
in regional loading conditions may thus result in 
regional discoordinate diastolic motion. 
In relation to this, the LV diastolic dysfunction 
and its regional differences may also play a role in 
the pathophysiology of diastolic dyssynchrony. It 
has been shown, that diastolic dyssynchrony cor-
related with the degree of LV diastolic dysfunction, 
prolonged relaxation and elevated pulmonary capil-
lary wedge pressure in patients with HFPEF, but 
also in HFREF [1, 5, 23]. The present study found 
that, although not statistically significant, patients 
with diastolic dyssynchrony had higher estimated 
LV filling pressure than those without. Several 
studies have additionally proposed, that right-to-
left ventricular diastolic interaction from raised 
right ventricular diastolic pressure could explain 
delayed onset of myocardial diastolic motion [24, 
25]. Differences in serum fibrosis markers repre-
senting different LV diastolic dysfunction stages 
might thus help to indicate patient with advanced 
diastolic dyssynchrony [26].
Another potential circumstance for the oc-
currence of diastolic dyssynchrony may include 
myocardial ischemia. It the present study, it was 
observed that a majority of patients with diastolic 
dyssynchrony had ischemic origin of HF, whereas 
DCM was more prevalent among those without. 
Data from several studies on diastolic dyssyn-
chrony in coronary artery disease come in line with 
the current observations. In 1 study diastolic dys-
synchrony was evident in patients with ischemic 
heart disease and preserved ejection fraction and 
correlated with lower diastolic LV function [27, 28]. 
In another, LV diastolic synchronicity was shown to 
be disrupted in patients with ST segment elevation 
myocardial infarction [29]. Interestingly, diastolic 
dyssynchrony recovered after successful coronary 
revascularization. Additionally, a study investigat-
ing the occurrence of diastolic dyssynchrony during 
Figure 3. Comparison of mean VO2peak between patients 
without rest diastolic dyssynchrony, who remained syn-
chronized at exercise (A) and those who dyssynchro-
nized at exercise (B); and between patients with rest 
diastolic dyssynchrony, who remained dyssnchronized 
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dobutamine stress echocardiography found that 
diastolic dyssynchrony imaging at peak dobutamine 
yielded high sensitivity and specificity in predicting 
significant coronary artery disease [30]. This might 
imply, that diastolic dyssynchrony is related to the 
presence of viable myocardium and could partly 
explain dynamic changes of diastolic dyssynchrony 
observed in the present study. In contrast to the 
previously cited study, diastolic dyssynchrony has 
been shown to improve during dobutamine stress 
echocardiography in patients with LV hypertrophy, 
demonstrating that the lusitropic effect of dobu-
tamine improve LV regional diastolic asynchrony 
led to an improvement of global LV diastolic fill-
ing [31]. Furthermore, CRT and medical therapy 
has been found to restore diastolic synchronicity. 
Wang et al. [5] who explored the effect of medical 
therapy on the extent of diastolic dyssynchrony in 
HF patients with preserved ejection fraction has 
shown, that the initiation of treatment with diu-
retics, beta-blockers and angiotensin-converting 
enzyme inhibitors or receptor blockers resulted 
in an improvement of diastolic dyssynchrony [5]. 
Accordingly, as wider QRS has been associated with 
the presence of diastolic dyssynchrony, it has been 
hypothesized, that CRT may also lead to diastolic 
resynchronization. Shanks et al. [3] observed a 
high incidence of diastolic dyssynchrony in CRT 
responders, and its sustained improvement with bi-
ventricular pacing. Although diastolic together with 
systolic dyssynchrony has been shown to normal-
ise with CRT in some patients, it is questionable 
whether the presence of diastolic dyssynchorny 
improves CRT patient selection. 
Diastolic dyssynchrony and its changes ap-
pear to have multifactorial pathophysiology, which 
include electrical and local mechanical properties 
of the myocardium, but the exact mechanism or 
clinical meaning remains uncertain. As discussed 
earlier, the presence of diastolic dyssynchrony may 
be attributed to myocardial ischemia or myocardial 
viability, as well as suboptimal medical therapy. 
Whether exercise-induced diastolic resynchroni-
zation could serve as a marker to guide therapy 
optimization requires further study.
Limitations of the study
The main strength of the present study is 
that it enriches a limited body of literature on the 
clinical implications of diastolic LV dyssynchrony 
and its exercise-induced changes in patients with 
HFREF and helps to improve our understanding 
of this phenomenon. 
Despite these advantages there are several 
limitations. It was a pilot, single-center study with 
a limited number of participants. A  limited number 
of LV dyssynchrony parameters were used. Meas-
urement of dyssynchrony at peak exercise may 
pose some difficulties caused by insufficient quality 
of echocardiographic recordings in up to 10% of pa-
tients. There was no attempt to evaluate the causes 
of diastolic dyssynchrony and its exercise-induced 
changes. Despite these drawbacks, it is believed 
that the consistency of the results validates the 
observations. Larger scale prospective studies are 
needed to validate the present results. 
Conclusions 
Diastolic dyssynchrony may change during 
exercise in half of HFREF patients. The ability to 
restore diastolic synchronicity at exercise predicts 
better aerobic capacity, whereas advanced age, 
ischemic etiology, prolonged PR interval and more 
advanced diastolic dysfunction are associated with 
lower exercise tolerance. 
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